UQ Centre for Clinical Research, The University of Queensland, Herston, QLD 4029, Australia; School of Public Health, The University of Queensland, Cnr Wyndham St and Herston Road, Herston, QLD 4006, Australia.
Centre for Youth Substance Abuse Research, The University of Queensland, Herston, QLD 4029, Australia; National Addiction Centre, Kings College London, 4 Windsor Walk, Denmark Hill, London SE5 8BB, United Kingdom.
Int J Drug Policy. 2015 Jun;26(6):548-53. doi: 10.1016/j.drugpo.2015.02.003. Epub 2015 Mar 3.
Australia has some of the most restrictive laws concerning use of nicotine in e-cigarettes. The only current legal option for Australians to legally possess and use nicotine for vaping is with a medical prescription and domestic supply is limited to compounding pharmacies that prepare medicines for specific patients. An alternative regulatory option that could be implemented under current drugs and poisons regulations is a 'nicotine licensing' scheme utilising current provisions for 'dangerous poisons'. This commentary discusses how such a scheme could be used to trial access to nicotine solutions for vaping outside of a 'medicines framework' in Australia.
澳大利亚在电子烟中使用尼古丁的法律限制最为严格。目前澳大利亚人合法拥有和使用尼古丁电子烟的唯一合法途径是凭处方购买,国内供应仅限于为特定患者配制药物的制剂药房。根据现行的毒品和毒药法规,可以采用另一种监管方案,即利用“危险毒药”的现行规定实行“尼古丁许可证”制度。本评论讨论了如何在澳大利亚的“药物框架”之外,利用这样一种制度来尝试获得尼古丁电子烟溶液。